Literature DB >> 6319057

Epstein-Barr virus induced pneumococcal antibody production in man. A comparison of different lymphoid organs.

A Freijd, A Rosén.   

Abstract

B cell enriched lymphocytes from different lymphoid organs were compared regarding their ability to produce pneumococcal polysaccharide (PPS) antibodies in vitro after transformation with Epstein-Barr virus. Tonsillar, adenoidal and peripheral blood lymphocytes (PBL) were studied. Fifty thousand B enriched lymphocytes from each organ sample were cultured in each of 88 wells of a microplate. After 30 days the supernatant of each culture was assayed for pneumococcal antibody activity and total IgG and IgM, using enzyme immunosorbent assay. Sera from the organ donors were analysed as well. In the supernatants, significant specific antibody activity was detected only of the IgM class, although IgG production was recorded. The IgM anti-PPS activity of PBL was significantly higher than that of the adenoidal lymphocytes (P less than 0.01), with tonsillar lymphocytes in an intermediate position, although the level of total IgM was of the same magnitude. Sera from children showed the highest IgM anti-PPS activity and at the same time the lowest IgG activity. The opposite relation was recorded in sera from the adult donors. Irrespective of the explanation for different distribution of specifically reactive cells in different lymphoid organs our data indicate distinct compartmentalization of immunocompetent B cell clones.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319057      PMCID: PMC1535793     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

Review 1.  A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.

Authors:  A G Bird; S Britton
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro.

Authors:  A Rosén; P Gergely; M Jondal; G Klein; S Britton
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

3.  The use of bacteria for the functional characterization of human lymphocyte subpopulations in various lymphoid organs.

Authors:  B Rynnel-Dagöö; O Ringdén; H Alfredsson; E Möller
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

4.  Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.

Authors:  D J Moss; A B Rickinson; J H Pope
Journal:  Int J Cancer       Date:  1978-12       Impact factor: 7.396

5.  Polyvalent pneumococcal polysaccharide vaccines.

Authors:  M R Hilleman; A A McLean; P P Vella; R E Weibel; A F Woodhour
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

6.  IgG on human blood lymphocytes studied by immunofluorescence.

Authors:  D Pettersson; H Mellstedt; G Holm
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

7.  Mitogens as probes for immunocyte activation and cellular cooperation.

Authors:  J Andersson; O Sjöberg; G Möller
Journal:  Transplant Rev       Date:  1972

8.  Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies.

Authors:  S Avrameas
Journal:  Immunochemistry       Date:  1969-01

9.  Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations.

Authors:  B Rynnel-Dagöö; E Möller; E Waterfield
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

10.  Frequencies of the separate human B cell subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen.

Authors:  O Martínez-Maza; S Britton
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  1 in total

1.  Chlamydial respiratory infection in childhood and spurious immunoglobulin M.

Authors:  K Persson; M Bröms
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.